[go: up one dir, main page]

Choi et al., 2016 - Google Patents

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis

Choi et al., 2016

View HTML
Document ID
2721616911604478983
Author
Choi M
Fritzler M
Publication year
Publication venue
Current Opinion in Rheumatology

External Links

Snippet

Despite substantial advances, the high morbidity and mortality that currently characterizes SSc can largely be attributed to a delay in diagnosis, gaps in our understanding of the role of autoantibodies in early disease, and limited effective therapeutic options. An early and …
Continue reading at journals.lww.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated

Similar Documents

Publication Publication Date Title
Choi et al. Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis
Fujimoto et al. Recent advances in dermatomyositis-specific autoantibodies
Cavagna et al. Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study
Pogorelic et al. Prospective validation of Alvarado score and Pediatric Appendicitis Score for the diagnosis of acute appendicitis in children
Chan et al. Risk factors associated with renal involvement in childhood Henoch-Schönlein purpura: a meta-analysis
Greenblatt et al. Preclinical rheumatoid arthritis and rheumatoid arthritis prevention
Gecse et al. Impact of disease location on fecal calprotectin levels in Crohn’s disease
Liu et al. Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis
Mooney et al. Elevated biomarkers of inflammation and coagulation in patients with HIV are associated with higher Framingham and VACS risk index scores
Ketelslegers et al. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients
Peng et al. Head-to-head comparison of the performance of 17 risk models for predicting presence of advanced neoplasms in colorectal cancer screening
Assayag et al. Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria
Sidhu et al. Faecal lactoferrin–a novel test to differentiate between the irritable and inflamed bowel?
Pittock et al. Inflammatory transverse myelitis: evolving concepts
Kolarz et al. The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients
Wunsch et al. Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Pradhan et al. Clinical and autoimmune profile of scleroderma patients from Western India
Vonkeman et al. The new European League Against Rheumatism/American College of Rheumatology diagnostic criteria for rheumatoid arthritis: how are they performing?
Sanmartí et al. Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study
Kim et al. Practical direct immunofluorescence
Wong et al. Clinical features, diagnosis, and management of the antiphospholipid syndrome
Lim Prevention of thrombosis in antiphospholipid syndrome
Al-Shukaili et al. Evaluation of anti‐mutated citrullinated vimentin antibodies, anti‐cyclic citrullinated peptide antibodies and rheumatoid factor in Omani patients with rheumatoid arthritis
Lim Thrombotic risk in the antiphospholipid syndrome
Finckh et al. Measuring ACPA in the general population or primary care: is it useful?